Dangerous Side Effects - Watch These Videos Before Use

Home

Dangerous Side Effects

All Time

Today

This week

This month

This year

What Medications Should Not Be Taken With Rifaximin? - Sensitive Stomach Guide Side Effects 2 Views • 1 month ago

What Medications Should Not Be Taken With Rifaximin? In this informative video, we discuss the important topic of medication interactions with Rifaximin, especially for those with sensitive stomachs, Irritable Bowel Syndrome (IBS), or colitis. Understanding which medications to avoid while taking Rifaximin can help you manage your health better and prevent unwanted side effects. We'll outline specific categories of medications that should be approached with caution, including live vaccines, certain antibiotics, antifungal medications, immunosuppressants, and blood thinners.

By being aware of potential interactions, you can make informed decisions about your treatment plan. We will also touch on the significance of communicating openly with your healthcare provider about all medications and supplements you are taking. Monitoring your body's reactions when starting Rifaximin alongside other medications is essential for maintaining your comfort and well-being.

Join us for this essential discussion on medication safety and health management. Subscribe to our channel for more helpful information tailored for those dealing with sensitive digestive issues.

⬇️ Subscribe to our channel for more valuable insights.

🔗Subscribe: https://www.youtube.com/@Sensi....tiveStomachGuide/?su

#Rifaximin #IBS #Colitis #SensitiveStomach #MedicationSafety #HealthManagement #DigestiveHealth #Antibiotics #Immunosuppressants #BloodThinners #HealthTips #GastrointestinalHealth #MedicationInteractions #PatientEducation #WellnessJourney

About Us: Welcome to Sensitive Stomach Guide! Our channel is dedicated to helping individuals navigate the challenges of digestive health. We cover a wide range of topics including Irritable Bowel Syndrome (IBS), IBS symptoms and triggers, the sensitive stomach diet, Inflammatory Bowel Disease (IBD), ulcerative colitis, Crohn’s disease, gut health tips, the low FODMAP diet, and managing bloating and gas, along with natural remedies for digestive issues. We aim to create a friendly and informative space where you can find support and practical advice tailored to your needs. The content provided is for general informational and educational purposes only. It is not intended to substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay seeking it because of something you have seen in this content. Never rely on this information in place of consulting with qualified healthcare professionals. The creators and distributors of this content are not responsible for any adverse effects or consequences resulting from the use of any suggestions, preparations, or procedures described in this material. Always consult with your healthcare provider before starting any new health-related practice or program.

If You Suffer from Premenstrual Dysphoria - Watch This Side Effects 2 Views • 1 month ago

PMDD stands for premenstrual dysphoric disorder. This is not to be confused with Premenstrual Syndrome or PMS. PMS is changes in mood during certain parts of the menstrual cycle. It affects 80% of women. The mood changes can be mild to moderate. In fact, some women will just see it as feeling a little moody the week before their menstrual cycle.

PMDD is a severe form of PMS. It’s almost like turning into the werewolf when the full moon rises. For some people, it’s just that drastic. It affects 3% - 8% of women. So it’s not as common as PMS.

We treat PMDD with antidepressants or hormone therapy. I show you why some women get PMDD and why the antidepressants help. I discuss the difference between intermittent and continuous dosing with antidepressants. I also discuss the two main hormone treatments.
If you do not want to take any kind of medication, you can try lifestyle changes. The first are diet modifications such as eliminating caffeine, sugar, nicotine and alcohol and minimizing sodium. You would combine this with sleeping 7-9 hours a night and getting regular exercise – like 3-5 times a week.

Some nutritional supplements have shown to be helpful. These would be Calcium 1200mg/day, Vitamin B6 50-100mg/day. Other supplements would be Magnesium 200 – 360mg/day, Vitamin E 400 IU/day.

There are some herbal remedies that have been shown in studies to be helpful.
Agnus castus fruit extract, also known as chasteberry and Gingko biloba.

To download the mood diary go here:
http://markspsychiatry.com/mood-diary/

Video on Brain Zaps from medication withdrawal
http://www.youtube.com/watch?v=KrcUEarpx-s

Want to know more about mental health and self-improvement? On this channel I discuss topics such as bipolar disorder, depression, anxiety disorders, attention deficit disorder (ADHD), relationships and personal development/self-improvement. If you don’t want to miss a video, click here to subscribe. https://goo.gl/DFfT33

References:
Article about how SSRI’s increase allopregnalone
Griffin LD, Mellon SH. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci U S A. 1999;96(23):13512–13517.
Bäckström T, Bixo M, et. al. Allopregnanolone and mood disorders. Prog Neurobiol. 2014 Feb; 113:88-94. Epub 2013 Aug 23.

Schiller CE, Schmidt PJ, Rubinow DR. Allopregnanolone as a mediator of affective switching in reproductive mood disorders. Psychopharmacology (Berl). 2014;231(17):3557–3567. doi:10.1007/s00213-014-3599-x

Griffin LD, Mellon SH. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci U S A. 1999;96(23):13512–13517.

Khine K, Rosenstein DL, Elin RJ, Niemela JE, Schmidt PJ, Rubinow DR. Magnesium (Mg) retention and mood effects after intravenous Mg infusion in premenstrual dysphoric disorder. Biol Psychiatry. 2006 Feb 15;59(4):327-33.

Yonkers KA, Pearlstein TB, Gotman N. A pilot study to compare fluoxetine, calcium, and placebo in the treatment of premenstrual syndrome. J Clin Psychopharmacol. 2013 Oct; 33(5):614-20.

Disclaimer: All of the information on this channel is for educational purposes and not intended to be specific/personal medical advice from me to you. Watching the videos or getting answers to comments/question, does not establish a doctor-patient relationship. If you have your own doctor, perhaps these videos can help prepare you for your discussion with your doctor.

Understanding TD Side Effects 2 Views • 1 month ago

See Important Safety Information below; Prescribing Information including Boxed Warning: https://bit.ly/3YhB0s9. AUSTEDO XR®/AUSTEDO® can cause depression, suicidal thoughts, or actions in patients with HD. Don’t use if you have liver problems; are taking reserpine, tetrabenazine, or valbenazine.
INDICATIONS & USAGE
AUSTEDO XR is indicated in adults for the treatment of chorea associated with Huntington's disease (HD) & for the treatment of tardive dyskinesia (TD).
IMPORTANT SAFETY INFORMATION
Depression & Suicidality in HD Patients: AUSTEDO XR can increase the risk of depression & suicidal thoughts & behavior (suicidality) in HD Patients. Balance the risks of depression & suicidality with the clinical need for treatment of chorea. Closely monitor patients for the emergence or worsening of depression, suicidality, or unusual changes in behavior. Inform patients, their caregivers, & families of the risk of depression & suicidality & instruct them to report behaviors of concern promptly to the treating physician. Exercise caution when treating patients with a history of depression or prior suicide attempts or ideation. AUSTEDO XR is contraindicated in patients who are suicidal, & in patients with untreated or inadequately treated depression.
Contraindications: AUSTEDO XR is contraindicated in HD patients who are suicidal, or have untreated or inadequately treated depression. AUSTEDO XR is also contraindicated in: patients with hepatic impairment; patients taking reserpine or within 20 days of discontinuing reserpine; patients taking monoamine oxidase inhibitors (MAOIs), or within 14 days of discontinuing MAOI therapy; & patients taking tetrabenazine or valbenazine.
Clinical Worsening & Adverse Events in HD Patients: AUSTEDO XR may cause a worsening in mood, cognition, rigidity, & functional capacity. Prescribers should periodically re-evaluate the need for AUSTEDO XR in their patients by assessing the effect on chorea & possible adverse effects.
QTc Prolongation: AUSTEDO XR may prolong the QT interval, but the degree of QT prolongation is not clinically significant when AUSTEDO XR is administered within the recommended dosage range. AUSTEDO XR should be avoided in patients with congenital long QT syndrome & in patients with a history of cardiac arrhythmias.
Neuroleptic Malignant Syndrome (NMS), a potentially fatal symptom complex reported in association with drugs that reduce dopaminergic transmission, has been observed in patients receiving tetrabenazine. The risk may be increased by concomitant use of dopamine antagonists or antipsychotics. The management of NMS should include immediate discontinuation of AUSTEDO XR; intensive symptomatic treatment & medical monitoring; & treatment of any concomitant serious medical problems.
Akathisia, Agitation, & Restlessness: AUSTEDO XR may increase the risk of akathisia, agitation, & restlessness. The risk of akathisia may be increased by concomitant use of dopamine antagonists or antipsychotics. If a patient develops akathisia, the AUSTEDO XR dose should be reduced; some patients may require discontinuation of therapy.
Parkinsonism: AUSTEDO XR may cause parkinsonism in TD or HD patients. The risk of parkinsonism may be increased by concomitant use of dopamine antagonists or antipsychotics. If a patient develops parkinsonism, the AUSTEDO XR dose should be reduced; some patients may require discontinuation of therapy.
Sedation & Somnolence: Sedation is a common dose-limiting adverse reaction of AUSTEDO XR. Patients should not perform activities requiring mental alertness, such as operating a motor vehicle or hazardous machinery, until they are on a maintenance dose of AUSTEDO XR & know how the drug affects them. Concomitant use of alcohol or other sedating drugs may have additive effects & worsen sedation & somnolence.
Hyperprolactinemia: Tetrabenazine elevates serum prolactin concentrations in humans. If there is a clinical suspicion of symptomatic hyperprolactinemia, appropriate laboratory testing should be done & consideration should be given to discontinuation of AUSTEDO XR.
Binding to Melanin-Containing Tissues: Deutetrabenazine or its metabolites bind to melanin-containing tissues & could accumulate in these tissues over time. Prescribers should be aware of the possibility of long-term ophthalmologic effects.
Common Adverse Reactions: The most common adverse reactions for AUSTEDO (greater than 8% & greater than placebo) in a controlled clinical study in HD patients were somnolence, diarrhea, dry mouth, & fatigue. The most common adverse reactions for AUSTEDO (4% & greater than placebo) in controlled clinical studies in TD patients were nasopharyngitis & insomnia. Adverse reactions with AUSTEDO XR are expected to be similar to AUSTEDO.